SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Right before the extended weekend, the stock price of Liquidmetal Technologies Inc (OTCMKTS:LQMT) jumped on the chart posting gains of 4.5% and closing week at $0.136 per share. The stock witnessed huge investors’ interest as the share volume was 2.1 million much higher than the 30-day average volume.

The stock didn’t register a green close on Monday but managed to sustain its gains. In last trading session, the stock price of Liquidmetal declined 0.74% to close the trading session at $0.135. The decline came at a share volume of 902,134 compared to average share volume of 1.48 million.

The momentum

Liquidmetal had registered a roller coaster ride so far in this year. Almost every green session has been immediately followed by a deep red session. What are the reasons behind this inconsistent performance? The company is a developer firm of the amorphous alloy known as Liquidmetal.

It is nearly 2.5 times sturdier than titanium. It is also 1.5 times rugged than stainless steel. In fact it is significant for company’s performance which is evident from the fact that Apple Inc. (NASDAQ:APPL) finalized a licensing agreement with company in 2010.

The deal

 Since 2010, the agreement between Apple and Liquidmetal Technologies Inc (OTCMKTS:LQMT) has been extended a number of times with the latest amendment recorded in May when the agreement was extended to February 5, 2016. The tech giant has used the Liquidmetal alloy in its device SIM ejectors. There have been rumours that Apple will use the material in next device.

With the ongoing buzz, the stock of Liquidmetal would have moved higher on the charts but it is not the case. The stock has been negatively impacted by the financial performance. Despite several years of measures to commercialize the Liquidmetal the results have not been encouraging. The 1Q2015 report reveals that revenues declined by 85% from the same period last year.